Small renal mass: What the urologist needs to know for treatment planning and assessment of treatment results

American Journal of Roentgenology

Volumn 196, Issue 6, 2011, Pages 1267-1273

  Stakhovskyi, Oleksandr ^a   Yap, Stanley A ^a   Leveridge, Michael ^a   Lawrentchuk, Nathan ^a   Jewett, Michael A S ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

Active surveillance of small renal mass; Kidney cancer; Kidney imaging; Kidney neoplasms; Small renal mass

Indexed keywords

COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CRYOABLATION; HIGH INTENSITY FOCUSED ULTRASOUND; HUMAN; KIDNEY BIOPSY; KIDNEY CARCINOMA; KIDNEY TUMOR; MINIMALLY INVASIVE SURGERY; NEPHRECTOMY; NUCLEAR MAGNETIC RESONANCE IMAGING; PARTIAL NEPHRECTOMY; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; RENOGRAPHY; REVIEW; TREATMENT OUTCOME; TREATMENT PLANNING; TUMOR VOLUME; UROLOGY;

BIOPSY, NEEDLE; DIAGNOSIS, DIFFERENTIAL; DIAGNOSTIC IMAGING; HUMANS; KIDNEY NEOPLASMS; NEOPLASM STAGING; PATIENT CARE PLANNING;

EID: 79960491313     PISSN: 0361803X     EISSN: 15463141     Source Type: Journal    
DOI: 10.2214/AJR.10.6336     Document Type: Review

References (74)

1. Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin 2010; 60:277-300
2. Reis LAG, Harkins D, Krapcho M, et al., eds. SEER Cancer Statistics Review, 1973-2007. Bethesda, MD: National Cancer Institute, 2010
3. Gill IS, Aron M, Gervais DA, Jewett MA. Clinical practice: small renal mass. N Engl J Med 2010; 362:624-634
4. Chow WH, Dong LM, Devesa SS. Epidemiology and risk factors for kidney cancer. Nat Rev Urol 2010; 7:245-257
5. Rioux-Leclercq N, Karakiewicz PI, Trinh QD, et al. Prognostic ability of simplified nuclear grading of renal cell carcinoma. Cancer 2007; 109:868-874 (Pubitemid 46333528)
6. Drucker BJ. Renal cell carcinoma: current status and future prospects. Cancer Treat Rev 2005; 31:536-545 (Pubitemid 41614811)
7. Frank I, Blute ML, Cheville JC, Lohse CM, Weaver AL, Zincke H. Solid renal tumors: an analysis of pathological features related to tumor size. J Urol 2003; 170:2217-2220 (Pubitemid 37413960)
8. Thompson RH, Kurta JM, Kaag M, et al. Tumor size is associated with malignant potential in renal cell carcinoma cases. J Urol 2009; 181:2033-2036
9. Hollingsworth JM, Miller DC, Daignault S, Hollenbeck BK. Rising incidence of small renal masses: a need to reassess treatment effect. J Natl Cancer Inst 2006; 98:1331-1334 (Pubitemid 44530728)
10. Volpe A, Jewett MA. Current role, techniques and outcomes of percutaneous biopsy of renal tumors. Expert Rev Anticancer Ther 2009; 9:773-783
11. Chawla SN, Crispen PL, Hanlon AL, Greenberg RE, Chen DY, Uzzo RG. The natural history of observed enhancing renal masses: meta-analysis and review of the world literature. J Urol 2006; 175:425-431 (Pubitemid 43067318)
12. UICC International Union Against Cancer. Sobin LH, Gospodarowicz MK, Wittekind C, eds. TNM classification of malignant tumors, 7th ed. Hoboken, NJ: Wiley-Blackwell, 2009
13. Greene FL, Page DL, Fleming ID, Fritz A. AJCC Cancer Staging Manual, 6th ed. New York, NY: Springer-Verlag Press, 2002
14. Kummerlin IP, ten Kate FJ, Wijkstra H, de la Rosette JJ, Laguna MP. Changes in the stage and surgical management of renal tumours during 1995-2005: an analysis of the Dutch national histopathology registry. BJU Int 2008; 102:946-951
15. Eble JN, Saulter G, Epstein JI, Sesterhenn IA, eds. Pathology and genetics of tumors in the urinary system and male genital organs: World Health Organization classification of tumors. Lyon, France: IARC Press, 2004:7
16. Patard JJ, Leray E, Rioux-Leclercq N, et al. Prognostic value of histologic subtypes in renal cell carcinoma: a multicenter experience. J Clin Oncol 2005; 23:2763-2771 (Pubitemid 46179466)
17. Pignot G, Elie C, Conquy S, et al. Survival analysis of 130 patients with papillary renal cell carcinoma: prognostic utility of type 1 and type 2 subclassification. Urology 2007; 69:230-235 (Pubitemid 46274917)
18. Leveridge MJ, Bostrom PJ, Koulouris G, Finelli A, Lawrentschuk N. Imaging renal cell carcinoma with ultrasonography, CT and MRI. Nat Rev Urol 2010; 7:311-325
19. Jamis-Dow CA, Choyke PL, Jennings SB, Linehan WM, Thakore KN, Walther MM. Small (< or = 3-cm) renal masses: detection with CT versus US and pathologic correlation. Radiology 1996; 198:785-788
20. Campbell SC, Novick AC, Belldegrun A, et al. Guideline for management of the clinical T1 renal mass. J Urol 2009; 182:1271-1279
21. Bluth EI, Bush WH Jr, Amis ES Jr, et al. Indeterminate renal masses: American College of Radiology. ACR Appropriateness Criteria. Radiology 2000; 215(suppl):747-752
22. Tamai H, Takiguchi Y, Oka M, et al. Contrast-enhanced ultrasonography in the diagnosis of solid renal tumors. J Ultrasound Med 2005; 24:1635-1640 (Pubitemid 41780705)
23. Fan L, Lianfang D, Jinfang X, Yijin S, Ying W. Diagnostic efficacy of contrast-enhanced ultrasonography in solid renal parenchymal lesions with maximum diameters of 5 cm. J Ultrasound Med 2008; 27:875-885 (Pubitemid 351913826)
24. Wilson SR, Greenbaum LD, Goldberg BB. Contrast-enhanced ultrasound: what is the evidence and what are the obstacles? AJR 2009; 193:55-60
25. Ljungberg B, Cowan NC, Hanbury DC, et al. EAU guidelines on renal cell carcinoma. Eur Urol 2010; 58:e29-e38
26. Kopka L, Fischer U, Zoeller G, Schmidt C, Ringert RH, Grabbe E. Dual-phase helical CT of the kidney: value of the corticomedullary and nephrographic phase for evaluation of renal lesions and preoperative staging of renal cell carcinoma. AJR 1997; 169:1573-1578 (Pubitemid 127469782)
27. Yuh BI, Cohan RH. Different phases of renal enhancement: role in detecting and characterizing renal masses during helical CT. AJR 1999; 173:747-755 (Pubitemid 29395305)
28. Israel GM, Bosniak MA. How I do it: evaluating renal masses. Radiology 2005; 236:441-450 (Pubitemid 41023424)
29. Siegel CL, Fisher AJ, Bennett HF. Interobserver variability in determining enhancement of renal masses on helical CT. AJR 1999; 172:1207-1212 (Pubitemid 29507607)
30. Zhang J, Lefkowitz RA, Ishill NM, et al. Solid renal cortical tumors: differentiation with CT. Radiology 2007; 244:494-504 (Pubitemid 47080882)
31. Sheir KZ, El-Azab M, Mosbah A, El-Baz M, Shaaban AA. Differentiation of renal cell carcinoma subtypes by multislice computerized tomography. J Urol 2005; 174:451-455, discussion 455
32. Kim JI, Cho JY, Moon KC, Lee HJ, Kim SH. Segmental enhancement inversion at biphasic multidetector CT: characteristic finding of small renal oncocytoma. Radiology 2009; 252:441-448
33. Choudhary S, Rajesh A, Mayer NJ, Mulcahy KA, Haroon A. Renal oncocytoma: CT features cannot reliably distinguish oncocytoma from other renal neoplasms. Clin Radiol 2009; 64:517-522
34. Bosniak MA. Angiomyolipoma (hamartoma) of the kidney: a preoperative diagnosis is possible in virtually every case. Urol Radiol 1981; 3:135-142 (Pubitemid 12139065)
35. Kim JK, Park SY, Shon JH, Cho KS. Angiomyolipoma with minimal fat: differentiation from renal cell carcinoma at biphasic helical CT. Radiology 2004; 230:677-684 (Pubitemid 38252861)
36. Tello R, Davison BD, O'Malley M, et al. MR imaging of renal masses interpreted on CT to be suspicious. AJR 2000; 174:1017-1022 (Pubitemid 30179995)
37. Shinmoto H, Yuasa Y, Tanimoto A, et al. Small renal cell carcinoma: MRI with pathologic correlation. J Magn Reson Imaging 1998; 8:690-694 (Pubitemid 28267793)
38. Silverman SG, Israel GM, Herts BR, Richie JP. Management of the incidental renal mass. Radiology 2008; 249:16-31
39. Hecht EM, Israel GM, Krinsky GA, et al. Renal masses: quantitative analysis of enhancement with signal intensity measurements versus qualitative analysis of enhancement with image subtraction for diagnosing malignancy at MR imaging. Radiology 2004; 232:373-378 (Pubitemid 38971275)
40. Somani BK, Nabi G, Thorpe P, N'Dow J, Swami S, McClinton S. Image-guided biopsy-diagnosed renal cell carcinoma: critical appraisal of technique and long-term follow-up. Eur Urol 2007; 51:1289-1295, discussion 96-97
41. Volpe A, Mattar K, Finelli A, et al. Contemporary results of percutaneous biopsy of 100 small renal masses: a single center experience. J Urol 2008; 180:2333-2337
42. Gill IS, Kavoussi LR, Lane BR, et al. Comparison of 1,800 laparoscopic and open partial nephrectomies for single renal tumors. J Urol 2007; 178:41-46 (Pubitemid 46898481)
43. Lane BR, Samplaski MK, Herts BR, Zhou M, Novick AC, Campbell SC. Renal mass biopsy: a renaissance? J Urol 2008; 179:20-27
44. Herts BR, Baker ME. The current role of percutaneous biopsy in the evaluation of renal masses. Semin Urol Oncol 1995; 13:254-261
45. Leveridge MJ, Schiff D, Chung H, et al. Small renal mass needle biopsy: outcomes of non-diagnostic percutaneous biopsy and role of repeat biopsy. J Urol 2010; 183(suppl):e321
46. Robson CJ, Churchill BM, Anderson W. The results of radical nephrectomy for renal cell carcinoma. J Urol 1969; 101:297-301
47. Frank I, Blute ML, Leibovich BC, Cheville JC, Lohse CM, Zincke H. Independent validation of the 2002 American Joint Committee on cancer primary tumor classification for renal cell carcinoma using a large, single institution cohort. J Urol 2005; 173:1889-1892
48. Patard JJ, Shvarts O, Lam JS, et al. Safety and efficacy of partial nephrectomy for all T1 tumors based on an international multicenter experience. J Urol 2004; 171:2181-2185, quiz 435
49. McKiernan J, Simmons R, Katz J, Russo P. Natural history of chronic renal insufficiency after partial and radical nephrectomy. Urology 2002; 59:816-820 (Pubitemid 34522166)
50. Huang WC, Levey AS, Serio AM, et al. Chronic kidney disease after nephrectomy in patients with renal cortical tumours: a retrospective cohort study. Lancet Oncol 2006; 7:735-740 (Pubitemid 44283660)
51. Van Poppel H, Da Pozzo L, Albrecht W, et al. A prospective randomized EORTC intergroup phase 3 study comparing the complications of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma. Eur Urol 2007; 51:1606-1615 (Pubitemid 46634740)
52. Fergany AF, Hafez KS, Novick AC. Long-term results of nephron sparing surgery for localized renal cell carcinoma: 10-year follow-up. J Urol 2000; 163:442-445 (Pubitemid 30060489)
53. Uzzo RG, Novick AC. Nephron sparing surgery for renal tumors: indications, techniques and outcomes. J Urol 2001; 166:6-18 (Pubitemid 32565331)
54. Burgess NA, Koo BC, Calvert RC, Hindmarsh A, Donaldson PJ, Rhodes M. Randomized trial of laparoscopic v open nephrectomy. J Endourol 2007; 21:610-613 (Pubitemid 47236185)
55. Becker F, Siemer S, Humke U, Hack M, Ziegler M, Stockle M. Elective nephron sparing surgery should become standard treatment for small unilateral renal cell carcinoma: long-term survival data of 216 patients. Eur Urol 2006; 49:308-313 (Pubitemid 43197871)
56. Rogers CG, Metwalli A, Blatt AM, et al. Robotic partial nephrectomy for renal hilar tumors: a multiinstitutional analysis. J Urol 2008; 180: 2353-2356, discussion 6
57. Hwang JJ, Walther MM, Pautler SE, et al. Radio frequency ablation of small renal tumors: intermediate results. J Urol 2004; 171:1814-1818 (Pubitemid 38501009)
58. Rehman J, Landman J, Lee D, et al. Needle-based ablation of renal parenchyma using microwave, cryoablation, impedance- and temperature-based monopolar and bipolar radiofrequency, and liquid and gel chemoablation: laboratory studies and review of the literature. J Endourol 2004; 18:83-104 (Pubitemid 38295672)
59. Zagoria RJ, Traver MA, Werle DM, Perini M, Hayasaka S, Clark PE. Oncologic efficacy of CTguided percutaneous radiofrequency ablation of renal cell carcinomas. AJR 2007; 189:429-436 (Pubitemid 47195930)
60. Tracy CR, Raman JD, Donnally C, Trimmer CK, Cadeddu JA. Durable oncologic outcomes after radiofrequency ablation: experience from treating 243 small renal masses over 7.5 years. Cancer 2010; 116:3135-3142
61. Rendon RA, Kachura JR, Sweet JM, et al. The uncertainty of radio frequency treatment of renal cell carcinoma: findings at immediate and delayed nephrectomy. J Urol 2002; 167:1587-1592 (Pubitemid 34240679)
62. Chosy SG, Nakada SY, Lee FT Jr, Warner TF. Monitoring renal cryosurgery: predictors of tissue necrosis in swine. J Urol 1998; 159:1370-1374 (Pubitemid 28172837)
63. Uchida M, Imaide Y, Sugimoto K, Uehara H, Watanabe H. Percutaneous cryosurgery for renal tumours. Br J Urol 1995; 75:132-136, discussion 6-7
64. Permpongkosol S, Nielsen ME, Solomon SB. Percutaneous renal cryoablation. Urology 2006; 68:19-25 (Pubitemid 44061932)
65. Atwell TD, Callstrom MR, Farrell MA, et al. Percutaneous renal cryoablation: local control at mean 26 months of followup. J Urol 2010; 184: 1291-1295
66. Laguna MP, Beemster P, Kumar V, et al. Perioperative morbidity of laparoscopic cryoablation of small renal masses with ultrathin probes: a European multicentre experience. Eur Urol 2009; 56:355-361
67. Guazzoni G, Cestari A, Buffi N, et al. Oncologic results of laparoscopic renal cryoablation for clinical T1a tumors: 8 years of experience in a single institution. Urology 2010; 76:624-629
68. Kunkle DA, Uzzo RG. Cryoablation or radiofrequency ablation of the small renal mass: a metaanalysis. Cancer 2008; 113:2671-2680
69. Klatte T, Marberger M. High-intensity focused ultrasound for the treatment of renal masses: current status and future potential. Curr Opin Urol 2009; 19:188-191
70. Hegarty NJ, Gill IS, Desai MM, Remer EM, O'Malley CM, Kaouk JH. Probe-ablative nephron-sparing surgery: cryoablation versus radiofrequency ablation. Urology 2006; 68:7-13 (Pubitemid 44061929)
71. Crispen PL, Viterbo R, Boorjian SA, Greenberg RE, Chen DY, Uzzo RG. Natural history, growth kinetics, and outcomes of untreated clinically localized renal tumors under active surveillance. Cancer 2009; 115:2844-2852
72. Sowery RD, Siemens DR. Growth characteristics of renal cortical tumors in patients managed by watchful waiting. Can J Urol 2004; 11:2407-2410
73. The American College of Radiology. ACR appropriateness criteria: follow-up of renal cell carcinoma. American College of Radiology Website. www.acr.org/SecondaryMainMenuCategories/quality-safety/app-criteria/pdf/ ExpertPanelonUrologicImaging/FollowUpofRenalCellCarcinomaDoc5.aspx. Published 1996. Updated 2009. December 5, 2010
74. Jewett MAS, Finelli A, Link I, et al. Active surveillance of small renal masses: a prospective multi-center Canadian uro-oncology group trial. J Urol 2009; 181(suppl):320